Clinical Trial Update: Primary Prophylaxis for Spontaneous Bacterial Peritonitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial investigating primary prophylaxis for spontaneous bacterial peritonitis in decompensated cirrhosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Cirrhosis
• Small Bowel Bacterial Overgrowth Syndrome

Snippet

Sponsor: Changi General Hospital | Conditions: Decompensated Cirrhosis, Small Bowel Bacterial Overgrowth Syndrome | Phase 2, Phase 3 | Status: TERMINATED